TC Biopharm (Holdings) Plc
TCBPY
$0.4898
$0.219881.41%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.27M | 1.24M | 3.14M | 3.01M | 2.44M |
| Total Receivables | 1.59M | 1.52M | 1.40M | 1.34M | 3.08M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 583.00K | 974.00K | 1.06M | 1.01M | 630.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.55M | 1.57M | 1.67M | 1.60M | 144.40K |
| Total Current Assets | 4.99M | 5.31M | 7.26M | 6.96M | 6.29M |
|
|
|||||
| Total Current Assets | 4.99M | 5.31M | 7.26M | 6.96M | 6.29M |
| Net Property, Plant & Equipment | 2.92M | 3.10M | 3.33M | 3.19M | 3.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 764.90K | 768.50K | 783.60K | 750.70K | 762.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.68M | 9.17M | 11.38M | 10.90M | 10.46M |
|
|
|||||
| Total Accounts Payable | 1.19M | 2.43M | 2.35M | 2.25M | 1.21M |
| Total Accrued Expenses | 2.64M | 2.77M | 3.07M | 2.94M | 1.69M |
| Short-term Debt | -- | -- | -- | -- | 620.40K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 397.80K | 389.20K | 388.90K | 372.60K | 380.00K |
| Total Finance Division Other Current Liabilities | 225.80K | 425.80K | 243.40K | 233.20K | 1.89M |
| Total Other Current Liabilities | 225.80K | 425.80K | 243.40K | 233.20K | 1.89M |
| Total Current Liabilities | 4.46M | 6.02M | 6.05M | 5.80M | 5.79M |
|
|
|||||
| Total Current Liabilities | 4.46M | 6.02M | 6.05M | 5.80M | 5.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 620.40K |
| Capital Leases | 1.69M | 1.79M | 1.91M | 1.83M | 2.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.15M | 7.81M | 7.96M | 7.62M | 7.91M |
|
|
|||||
| Common Stock & APIC | 58.32M | 54.61M | 52.89M | 50.67M | 23.55M |
| Retained Earnings | -55.79M | -53.25M | -49.47M | -47.39M | -42.24M |
| Treasury Stock & Other | -- | -- | -- | -- | 21.24M |
| Total Common Equity | 2.53M | 1.36M | 3.42M | 3.28M | 2.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.53M | 1.36M | 3.42M | 3.28M | 2.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.53M | 1.36M | 3.42M | 3.28M | 2.55M |
|
|
|||||